Home / Healthcare / Global Nebulizer Market Research Report (2019-2026)
Report Image

Global Nebulizer Market Research Report (2019-2026)

ID:MR2398 | Jun-2020 | Global | 125 Pages

COVID-19

Get in-depth analysis of the COVID-19 impact on this Market

At 7.8% CAGR, Nebulizer Market Size is expected to Exhibit USD 1636.6 million by 2026, according to the analysis of MarketandReport.

Scope of the Report:

The detailed market intelligence report on the Global Nebulizer Market Covers the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Nebulizer Market place for the forecast 2019-2026.

Nebulizer Market Size, Share & Trends Analysis Report By Type (Jet, Mesh, Ultrasonic), By End Use (Hospitals and Clinics, Emergency Centers), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2020 - 2026

The high growth is attributed to the rising incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population. As per lung.org, in 2018, Chronic Obstructive Pulmonary Disease (COPD) is the leading cause of death in U.S.

Moreover, rising consumption of alcohol, tobacco, ultra-processed products, including sugar-sweetened beverages is a major cause behind the increasing prevalence of respiratory diseases in North America. According to the Centers for Disease Control and Prevention (CDC) data, about 14% of deaths in adults aged 30 to 70 years in North America are caused due to tobacco consumption. Thus, an increase in number of smokers and environmental pollution is anticipated to increase the demand for nebulizers.

The Major Players are covered:

Teleflex Medical, Inc.

Trudell Medical International

Briggs Healthcare

PARI Respiratory Equipment, Inc.

Omron Healthcare, Inc.

Allied Healthcare Products, Inc.

GF HEALTH PRODUCTS, INC.

DeVilbiss Healthcare LLC

Koninklijke Philips N.V.

 …

 

Market Opportunity

Rapid Transmission of the COVID-19 Infection to Create Immediate Growth Opportunities

The SARS-CoV-2 infection attacks the respiratory tract and lungs, causing shortness of breath, acute breathing problems, and pneumonia, along with a persistent fever and cough. People with preexisting lung disorders such as asthma are at high risk of contracting the COVID-19 infection. According to the Centers for Disease Control and Prevention (CDC), asthma patients are highly recommended to carry inhalers or portable Nebulizer with them as these devices can efficiently open the lungs and allow them to function normally. In this scenario, the uptake of inhalable drug delivery devices is likely to spike and favor the Nebulizer market growth. The only worry with these devices, as pointed out by the Asthma and Allergy Foundation of America, is their potential to transmit the infection among patients as well as healthcare workers, especially in healthcare facilities. If this issue is addressed, players can capitalize on the current pandemic and expand their presence in the market. 

Regional Analysis

Strong Healthcare Infrastructure to Support Market Growth in North America

North America boasted a market size of USD 308.4 million in 2019 and the region is likely to lead the Nebulizer market share during the forecast period. This is chiefly attributable to the presence of a robust healthcare infrastructure and patient-friendly reimbursement policies. In addition to this, escalating number of COVID-19 cases in the US will skyrocket the demand for Nebulizer and inhalers in 2020. Similar trends are expected to be observed in Europe. On the other hand, the market is Asia-Pacific is slated for steady expansion owing to the proliferation of medical device companies and rising prevalence of chronic respiratory disorders.

Market Drivers

Respiratory illnesses have become a major concern around the globe. Rising burden of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and increasing adoption of sedentary lifestyle are likely to accelerate the demand for effective drug delivery devices, further propelling this market growth. According to a report published by Forum of International Respiratory Societies (FIRS), in 2019, around 384 million people suffered from chronic obstructive pulmonary disease (COPD) and the number of cases is anticipated to surge in the coming years.  A significant growth in population along with the rise in air pollution and increase in the smoking rates in the emerging economies are anticipated to escalate the incidence of respiratory diseases in emerging countries. Moreover, the changing pattern of asthma with the age and rise in the incidence childhood asthma are likely to boost the usage of portable devices during the forecast period. According to American Lung Association (ALA), in 2016 in the U.S., approximately 3.5 million children below 18 years suffered an asthma attack. The increasing incidence of asthma in children is anticipated to fortify the demand for these devices during the forecast period.

For Detailed Report Request a Sample Report.


  Single user                       $ 1690.00
  Corporate-User                $ 3690.00

PERSONALIZE THIS RESEARCH

  • Any level of Personalization
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Get Data as per your Format and Definition
  • Triangulate with your Own Data